6rq7
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Gadolinium MRI contrast compound binding in human plasma glycoprotein afamin - resurrection of highly anisotropic data== | |
| - | + | <StructureSection load='6rq7' size='340' side='right'caption='[[6rq7]], [[Resolution|resolution]] 2.69Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6rq7]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6RQ7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6RQ7 FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DO3:10-((2R)-2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE+1,4,7-TRIACETIC+ACID'>DO3</scene>, <scene name='pdbligand=GD:GADOLINIUM+ATOM'>GD</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | |
| - | [[Category: | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5okl|5okl]], [[6fak|6fak]]</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6rq7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6rq7 OCA], [http://pdbe.org/6rq7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6rq7 RCSB], [http://www.ebi.ac.uk/pdbsum/6rq7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6rq7 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/AFAM_HUMAN AFAM_HUMAN]] Vitamin E binding protein. May transport vitamin E in body fluids under conditions where the lipoprotein system is not sufficient. May be involved in the regulation and transport of vitamin E at the blood-brain barrier.<ref>PMID:12463752</ref> <ref>PMID:15952736</ref> <ref>PMID:19046407</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Bowler, M W]] | ||
| + | [[Category: Juyoux, P]] | ||
| + | [[Category: Naschberger, A]] | ||
| + | [[Category: Rupp, B]] | ||
| + | [[Category: VonVelsen, J]] | ||
| + | [[Category: Afamin]] | ||
| + | [[Category: Conformational variability]] | ||
| + | [[Category: Gadoteridol]] | ||
| + | [[Category: Glycoprotein]] | ||
| + | [[Category: Hydrophobic ligand]] | ||
| + | [[Category: Transport protein]] | ||
| + | [[Category: Wnt-signalling]] | ||
Revision as of 05:59, 10 July 2019
Gadolinium MRI contrast compound binding in human plasma glycoprotein afamin - resurrection of highly anisotropic data
| |||||||||||
